Statutory Legal Notice & Disclosures

Official Disclaimers & Regulatory Disclosures

Comprehensive statutory non-reliance disclaimers, financial market limitations, medical reporting standards, third-party advertising disclosures, and liability parameters governing ZyvenPress.

Last Revised: September 2026 • Version 4.2 International • Statutory Non-Reliance

1. General Informational & Journalistic Purpose

All content published by ZyvenPress — including breaking dispatches, feature investigations, market commentary, audio podcasts, newsletter briefings, and infographics — is provided strictly for general educational, journalistic, and informational purposes.

While our editorial team exercises rigorous verification protocols prior to release, ZyvenPress makes no representations, warranties, or guarantees, express or implied, regarding the absolute completeness, continuous availability, or real-time precision of any piece of published content.

2. Financial Markets, Stocks & Cryptocurrency Non-Reliance

Financial reporting requires strict regulatory non-reliance disclosures under international securities frameworks (including SEBI in India, SEC in the United States, FCA in the United Kingdom, and ESMA in the European Union):

Not Licensed Financial or Investment Advice: Nothing published on ZyvenPress constitutes a solicitation, recommendation, endorsement, or offer to buy, sell, or hold any security, cryptocurrency token, commodity, derivative, or financial instrument. ZyvenPress is an independent newsroom, not a registered investment advisor, broker-dealer, or financial intermediary.

  • Ticker Data Latency: Real-time market tickers, stock quotes (NIFTY, S&P 500, NASDAQ, FTSE), and crypto metrics displayed on our portal may be delayed by 15 minutes or more in accordance with exchange reporting standards.
  • Capital Risk Warning: Capital markets, equities, foreign exchange, and digital assets carry inherent volatility and substantial risk of partial or total financial loss. Past market performance is never an indicator of future returns.
  • Mandatory Due Diligence: Readers must conduct their own independent research and consult licensed, certified financial planners, tax consultants, and legal advisors before executing any financial transaction.

3. Medical, Public Health & Scientific Reporting Disclaimer

Our coverage of medical breakthroughs, pharmaceutical clinical trials, epidemiological data, and wellness guidance is produced under accredited scientific journalistic standards:

  • Not Professional Medical Advice: Content published on ZyvenPress does not constitute individual clinical advice, medical diagnosis, or treatment plans. It must never be utilized as a substitute for consultation with a qualified medical physician or healthcare professional.
  • No Doctor-Patient Relationship: Consuming, sharing, or inquiring about health articles on ZyvenPress does not establish a doctor-patient, therapist-client, or clinical relationship of any nature.
  • Emergency Protocol: If you believe you are experiencing a medical emergency, acute distress, or an adverse pharmaceutical reaction, immediately call your local emergency medical services or visit the nearest hospital.

5. Columnist Opinions, Editorials & Guest Commentary

ZyvenPress provides an open forum for democratic debate and diverse intellectual discourse:

  • Author Autonomy: The views, opinions, arguments, and commentary expressed in columns, op-eds, guest essays, and video panels reflect exclusively the personal perspectives of the bylined author.
  • No Institutional Endorsement: Unless explicitly identified as an unsigned "ZyvenPress Editorial Board Statement", guest columns do not represent the official stance, political viewpoint, or corporate endorsement of ZyvenPress, its founder, or its managing editor.

7. Programmatic Advertising & Sponsored Dispatches (FTC / ASCI)

In full compliance with international advertising standards (FTC in the USA, ASCI in India, ASA in the UK):

  • Ad Network Independence: Display advertisements appearing on ZyvenPress are served dynamically via Google AdSense and accredited programmatic ad exchanges. ZyvenPress does not personally test, guarantee, or endorse products or services promoted in ad units.
  • Sponsored Content Labeling: Any commercial piece produced in collaboration with a paying sponsor is unmistakably marked with badges such as "Sponsored Content" or "Partner Dispatch", completely segregated from editorial reporting.

8. Forward-Looking Statements & Forecasting Projections

Articles discussing future corporate earnings, macroeconomic GDP forecasts, geopolitical elections, technological roadmaps, or central bank interest rate decisions often contain forward-looking statements. These statements are based on current market assumptions subject to unforeseen risks, geopolitical shifts, and market turbulence. Actual real-world events may differ materially from analytical forecasts.

9. Limitation of Liability & Reader Indemnification

To the maximum extent permitted by applicable law, in no event shall ZyvenPress, its founder, Managing Editor (Arsh Mansoori, Managing Editor & Publisher), correspondents, technology partners, or licensors be held liable for:

  • Any direct, indirect, incidental, punitive, or consequential damages resulting from the use of, or inability to use, our news services.
  • Any investment losses, portfolio drawdown, lost business profits, or tax penalties incurred through reliance on market tickers, articles, or analysis published on this portal.
  • Any interruption, latency, server downtime, virus transmission, or typographical error in content delivery.

Your sole and exclusive remedy for dissatisfaction with the site or its content is to discontinue accessing ZyvenPress.

10. Regulatory Governance & Formal Legal Desk

For inquiries regarding statutory compliance, legal disclosures, rights clearances, or formal regulatory concerns, please contact our designated operations desks:

Editorial & Legal Governance Desk

Arsh Mansoori, Managing Editor & Publisher

Managing Editor & Publisher • ZyvenPress

official@zyvenpress.com • legal@zyvenpress.com

Contact Legal Desk